141 related articles for article (PubMed ID: 28182013)
1. Duodenal GLP-1 signaling regulates hepatic glucose production through a PKC-δ-dependent neurocircuitry.
Yang M; Wang J; Wu S; Yuan L; Zhao X; Liu C; Xie J; Jia Y; Lai Y; Zhao AZ; Boden G; Li L; Yang G
Cell Death Dis; 2017 Feb; 8(2):e2609. PubMed ID: 28182013
[TBL] [Abstract][Full Text] [Related]
2. Gut ghrelin regulates hepatic glucose production and insulin signaling via a gut-brain-liver pathway.
Lin Y; Liang Z; He L; Yang M; Liu D; Gu HF; Liu H; Zhu Z; Zheng H; Li L; Yang G
Cell Commun Signal; 2019 Jan; 17(1):8. PubMed ID: 30683114
[TBL] [Abstract][Full Text] [Related]
3. Duodenal mucosal protein kinase C-δ regulates glucose production in rats.
Kokorovic A; Cheung GW; Breen DM; Chari M; Lam CK; Lam TK
Gastroenterology; 2011 Nov; 141(5):1720-7. PubMed ID: 21704002
[TBL] [Abstract][Full Text] [Related]
4. Duodenal activation of cAMP-dependent protein kinase induces vagal afferent firing and lowers glucose production in rats.
Rasmussen BA; Breen DM; Luo P; Cheung GW; Yang CS; Sun B; Kokorovic A; Rong W; Lam TK
Gastroenterology; 2012 Apr; 142(4):834-843.e3. PubMed ID: 22245844
[TBL] [Abstract][Full Text] [Related]
5. Brain GLP-1 signaling regulates femoral artery blood flow and insulin sensitivity through hypothalamic PKC-δ.
Cabou C; Vachoux C; Campistron G; Drucker DJ; Burcelin R
Diabetes; 2011 Sep; 60(9):2245-56. PubMed ID: 21810595
[TBL] [Abstract][Full Text] [Related]
6. Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats.
Duca FA; Côté CD; Rasmussen BA; Zadeh-Tahmasebi M; Rutter GA; Filippi BM; Lam TK
Nat Med; 2015 May; 21(5):506-11. PubMed ID: 25849133
[TBL] [Abstract][Full Text] [Related]
7. Duodenal PKC-δ and cholecystokinin signaling axis regulates glucose production.
Breen DM; Yue JT; Rasmussen BA; Kokorovic A; Cheung GW; Lam TK
Diabetes; 2011 Dec; 60(12):3148-53. PubMed ID: 21984583
[TBL] [Abstract][Full Text] [Related]
8. The insulinotropic effect of exogenous glucagon-like peptide-1 is not affected by acute vagotomy in anaesthetized pigs.
Veedfald S; Hansen M; Christensen LW; Larsen SA; Hjøllund KR; Plamboeck A; Hartmann B; Deacon CF; Holst JJ
Exp Physiol; 2016 Jul; 101(7):895-912. PubMed ID: 27027735
[TBL] [Abstract][Full Text] [Related]
9. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake.
Sandoval DA; Bagnol D; Woods SC; D'Alessio DA; Seeley RJ
Diabetes; 2008 Aug; 57(8):2046-54. PubMed ID: 18487451
[TBL] [Abstract][Full Text] [Related]
10. Brain GLP-1 and insulin sensitivity.
Sandoval D; Sisley SR
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():27-32. PubMed ID: 25724479
[TBL] [Abstract][Full Text] [Related]
11. Short-chain fatty acid sensing in rat duodenum.
Akiba Y; Inoue T; Kaji I; Higashiyama M; Narimatsu K; Iwamoto K; Watanabe M; Guth PH; Engel E; Kuwahara A; Kaunitz JD
J Physiol; 2015 Feb; 593(3):585-99. PubMed ID: 25433076
[TBL] [Abstract][Full Text] [Related]
12. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
Carmody JS; Muñoz R; Yin H; Kaplan LM
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
[TBL] [Abstract][Full Text] [Related]
13. Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives.
Jin T; Weng J
Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E620-7. PubMed ID: 27507553
[TBL] [Abstract][Full Text] [Related]
14. Reduction of hepatic insulin clearance after oral glucose ingestion is not mediated by glucagon-like peptide 1 or gastric inhibitory polypeptide in humans.
Meier JJ; Holst JJ; Schmidt WE; Nauck MA
Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E849-56. PubMed ID: 17609256
[TBL] [Abstract][Full Text] [Related]
15. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY
Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
[TBL] [Abstract][Full Text] [Related]
16. GLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products.
Guglielmi V; Sbraccia P
Eat Weight Disord; 2017 Jun; 22(2):231-240. PubMed ID: 28040864
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic glucagon signaling inhibits hepatic glucose production.
Mighiu PI; Yue JT; Filippi BM; Abraham MA; Chari M; Lam CK; Yang CS; Christian NR; Charron MJ; Lam TK
Nat Med; 2013 Jun; 19(6):766-72. PubMed ID: 23685839
[TBL] [Abstract][Full Text] [Related]
18. Neprilysin deficiency reduces hepatic gluconeogenesis in high fat-fed mice.
Esser N; Mongovin SM; Mundinger TO; Barrow BM; Zraika S
Peptides; 2023 Oct; 168():171076. PubMed ID: 37572792
[TBL] [Abstract][Full Text] [Related]
19. Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice.
Kooijman S; Wang Y; Parlevliet ET; Boon MR; Edelschaap D; Snaterse G; Pijl H; Romijn JA; Rensen PC
Diabetologia; 2015 Nov; 58(11):2637-46. PubMed ID: 26254578
[TBL] [Abstract][Full Text] [Related]
20. Monounsaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1.
Rocca AS; LaGreca J; Kalitsky J; Brubaker PL
Endocrinology; 2001 Mar; 142(3):1148-55. PubMed ID: 11181530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
